FindTrial
Sign In

The role of BAFF, APRIL and the clinical significance of apoptotic factors in hepatocellular carcinoma

The role of BAFF, APRIL and the clinical significance of apoptotic factors in hepatocellular carcinoma - BAFF, APRIL,apoptotic factors in hepatocellular carcinoma

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000016944
Enrollment
400
Registered
2015-03-27
Start date
2015-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Sponsors

Ehime University Graduate School of Medicine,Gastroenterology and Metabology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) liver cancer, hepatitis, cases and healthy men and women perform a liver resection. 2) at the time of obtaining informed consent, is older than 20 years old. 3) subjects consent was obtained from the person in writing about the present study participation.

Exclusion criteria

Exclusion criteria: 1) blood collection and liver tissue of harvesting is considered a health hazard. 2) age is less than 20 years old. 3) subjects for this study participated written consent was not obtained from the person.

Design outcomes

Primary

MeasureTime frame
To clarify the possibilities as a clinical marker and hepatocellular cancer therapeutic targets.—

Countries

Japan

Contacts

Public ContactYoshinori Ohno

Ehime University Graduate School of Medicine Gastroenterology and Metabology

ynori1975@gmail.com089-960-5308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026